Filament Health Corp (NEO:FH, OTCQB:FLHLF) reported that Chris Wagner has resigned as director from the board due to obligations in a new role, effective April 30, 2024.
Wagner, part of Filament's leadership since its inception, expressed confidence in the company's prospects. "I have been part of Filament's leadership team since the company was founded, and I firmly believe in its differentiated competitive position and prospects.
“I wish Filament nothing but success going forward."